Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on June 23, 2026

8 hours ago

MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D

Indeterminate GlobeNewswire

8 hours ago

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone

Indeterminate GlobeNewswire

8 hours ago

Tria Federal Appoints Former CMS and IRS CIO Rajiv Uppal to Advisory Board

Indeterminate GlobeNewswire

8 hours ago

Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire

8 hours ago

The XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH

Indeterminate GlobeNewswire

8 hours ago

Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel

Indeterminate GlobeNewswire

8 hours ago

Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform

Indeterminate GlobeNewswire

8 hours ago

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome

Indeterminate GlobeNewswire

8 hours ago

Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space

Indeterminate GlobeNewswire

8 hours ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

Indeterminate GlobeNewswire

8 hours ago

TOMI Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending

Indeterminate GlobeNewswire

8 hours ago

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire

8 hours ago

SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences

Indeterminate GlobeNewswire

8 hours ago

Premier Health of America Announces CCAA Proceedings

Indeterminate GlobeNewswire

8 hours ago

Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial

Indeterminate GlobeNewswire

9 hours ago

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

Indeterminate GlobeNewswire

9 hours ago

Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas

Indeterminate GlobeNewswire

9 hours ago

Integra LifeSciences Announces Key Executive Appointments

Indeterminate GlobeNewswire

9 hours ago

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

Indeterminate GlobeNewswire

9 hours ago

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

Indeterminate GlobeNewswire